##common.pageHeaderLogo.altText##
DOI:
https://doi.org/10.57187/4300

Original article

Vol. 156 No. 7 (2026)

Incidence of long COVID-related consultations in family medicine in Switzerland: a cross-sectional study within the Sentinella network

Cite this as:
Swiss Med Wkly. 2026;156:4300
Published
02.07.2026

Summary

STUDY AIMS: The initial prevalence estimates of long COVID exhibited significant heterogeneity. In Switzerland, early findings estimated a 39–53% prevalence of long COVID symptoms among adult patients who tested positive for SARS-CoV-2. However, studies conducted in a primary care setting suggested a significantly lower burden of care, with long COVID accounting for less than 1% of family medicine consultations. The objective of this study was to estimate the incidence of long COVID-related consultations in Swiss family medicine practices, in order to guide health services planning.

METHODS: This repeat cross-sectional study was conducted using the data collected by family physicians (general internists and paediatricians) within the Swiss Sentinella network, part of the epidemiological surveillance system managed by the Federal Office of Public Health. Data was collected between August 2021 and April 2023 via monthly reports of doctors’ activity over the past four weeks. Long COVID-related consultations were defined as visits where physicians recorded symptoms or conditions linked to post-acute SARS-CoV-2 effects, based on clinical definitions at the time. Doctor characteristics were measured and analysed for associations with monthly median incidence rates of long COVID-related consultations.

RESULTS: 181 family practices provided data for at least one month during the study (154 general internists and 27 paediatricians): 85% of doctors were general internists, 32% were women and 74% worked in an urban area. The median incidence of monthly long COVID-related consultations was 3/1000 consultations for general internists and 0/1000 consultations for paediatricians. Multivariable ordinal logistic regression showed that internists were significantly more likely to report long COVID-related consultations compared to paediatricians. Also, physicians in central Switzerland were more likely to have a higher median incidence of long COVID-related consultations in comparison to those in other regions.

CONCLUSIONS: Our study shows that the incidence of long COVID-related consultations in Swiss family medicine is markedly lower than expected, considering the estimated prevalence of long COVID post-SARS-CoV-2 infection. This discrepancy may result from potential biases in earlier studies, epidemiological variations and diagnostic challenges. These findings underscore the need for improved diagnostic criteria and enhanced support for primary care providers in recognising long COVID and facilitating referrals for more severely affected patients.

References

  1. 1. Nittas V, Puhan MA, Raineri A, Gao M, West E, Bürzie O. Long COVID: Evolving Definitions, Burden of Disease and Socio-Economic Consequences. Zurich: Epidemiology, Biostatistics and Prevention Institute, University of Zurich; 2022 nov. (Literature screening report).
  2. 2. Shah AD, Subramanian A, Lewis J, Dhalla S, Ford E, Haroon S, et al. Long Covid symptoms and diagnosis in primary care: A cohort study using structured and unstructured data in The Health Improvement Network primary care database. Ramagopalan SV, éditeur. PLOS ONE. 26 sept 2023;18(9):e0290583. doi: https://doi.org/10.1371/journal.pone.0290583
  3. 3. Rotar Pavlic D, Maksuti A, Mihevc M, Munda A, Medija K, Strauch V. Long COVID as a never-ending puzzle: the experience of primary care physicians. A qualitative interview study. BJGP Open. déc 2023;7(4):BJGPO.2023.0074.
  4. 4. Pavli A, Theodoridou M, Maltezou HC. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch Med Res. 2021 Aug;52(6):575–81. doi: https://doi.org/10.1016/j.arcmed.2021.03.010
  5. 5. Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022 Dec;54(1):1473–87. doi: https://doi.org/10.1080/07853890.2022.2076901
  6. 6. Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023 Mar;21(3):133–46. doi: https://doi.org/10.1038/s41579-022-00846-2
  7. 7. Clinical management of COVID-19: living guideline (7th version) . Geneva: World Health Organization; 2023 août.
  8. 8. Rando HM, Bennett TD, Byrd JB, Bramante C, Callahan TJ, Chute CG, et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. MedRxiv Prepr Serv Health Sci. 26 mars 2021;2021.03.20.21253896. doi: https://doi.org/10.1101/2021.03.20.21253896
  9. 9. Montenegro P, Moral I, Puy A, Cordero E, Chantada N, Cuixart L, et al. Prevalence of Post COVID-19 Condition in Primary Care: A Cross Sectional Study. Int J Environ Res Public Health. 2022 Feb;19(3):1836. doi: https://doi.org/10.3390/ijerph19031836
  10. 10. Henderson AD, Butler-Cole BF, Tazare J, Tomlinson LA, Marks M, Jit M, et al. Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis. 2023 [cited April 15 2024]. http://medrxiv.org/lookup/doi/10.1101/2023.12.04.23299364 10.1101/2023.12.04.23299364
  11. 11. Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023 May;381:e074425. doi: https://doi.org/10.1136/bmj-2022-074425
  12. 12. Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I; CoviCare Study Team. Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting. Ann Intern Med. 2021 Sep;174(9):1252–60. doi: https://doi.org/10.7326/M21-0878
  13. 13. Menges D, Ballouz T, Anagnostopoulos A, Aschmann HE, Domenghino A, Fehr JS, et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study. Simuunza MC, éditeur. PLOS ONE. 12 juill 2021;16(7):e0254523. doi: https://doi.org/10.1371/journal.pone.0254523
  14. 14. Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, et al.; the RegCOVID Research Group. Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study. J Gen Intern Med. 2022 Jun;37(8):1943–52. doi: https://doi.org/10.1007/s11606-021-07242-1
  15. 15. Dumont R, Richard V, Lorthe E, Loizeau A, Pennacchio F, Zaballa ME, et al.; SEROCoV-KIDS study group. A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents. Nat Commun. 2022 Nov;13(1):7086. doi: https://doi.org/10.1038/s41467-022-34616-8
  16. 16. Mueller Y, Auderset D, Maeder M, Schwarz J, Masserey E. Sentinel monitoring of COVID-related daily activity in primary care practices of the canton of Vaud. Eur J Public Health. 21 oct 2022;32(Supplement_3):ckac131.560.
  17. 17. Fumagalli C, Zocchi C, Tassetti L, Silverii MV, Amato C, Livi L, et al.; AOU Careggi COVID-19 Follow-up study Group. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med. 2022 Mar;97:36–41. doi: https://doi.org/10.1016/j.ejim.2021.11.018
  18. 18. Walker AJ, MacKenna B, Inglesby P, Tomlinson L, Rentsch CT, Curtis HJ, et al.; The OpenSAFELY Collaborative. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br J Gen Pract. 2021 Oct;71(712):e806–14. doi: https://doi.org/10.3399/BJGP.2021.0301
  19. 19. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102–7. doi: https://doi.org/10.1016/S1473-3099(21)00703-9
  20. 20. World Health Organization. 2023 data.who.int, WHO Coronavirus (COVID-19) dashboard > Data [Dashboard]. https://data.who.int/dashboards/covid19/data
  21. 21. Dorn M. OBSAN Bercicht 10/2023 - Erfahrungen der Wohnbevölkerung ab 18 Jahren mit dem Gesundheitssystem – Situation in der Schweiz und im internationalen Vergleich. Neuchâtel. Observatoire Suisse de la Santé (Obsan). 2023;(avr):55.
  22. 22. Wander PL, Baraff A, Fox A, Cho K, Maripuri M, Honerlaw JP, et al. Rates of ICD-10 Code U09.9 Documentation and Clinical Characteristics of VA Patients With Post-COVID-19 Condition. JAMA Netw Open. 2023 Dec;6(12):e2346783. doi: https://doi.org/10.1001/jamanetworkopen.2023.46783
  23. 23. Nguyen NN, Hoang VT, Lagier JC, Raoult D, Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021 Jun;27(6):931–2. doi: https://doi.org/10.1016/j.cmi.2020.12.021
  24. 24. Huerne K, Filion KB, Grad R, Ernst P, Gershon AS, Eisenberg MJ. Epidemiological and clinical perspectives of long COVID syndrome. Am J Med Open. 2023 Jun;9:100033. doi: https://doi.org/10.1016/j.ajmo.2023.100033
  25. 25. Pandharipande P, Williams Roberson S, Harrison FE, Wilson JE, Bastarache JA, Ely EW. Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness. Lancet Respir Med. 2023 Aug;11(8):726–38. doi: https://doi.org/10.1016/S2213-2600(23)00238-2
  26. 26. O’Hare AM, Vig EK, Iwashyna TJ, Fox A, Taylor JS, Viglianti EM, et al.; VA COVID Observational Research Collaboratory (CORC). Complexity and Challenges of the Clinical Diagnosis and Management of Long COVID. JAMA Netw Open. 2022 Nov;5(11):e2240332. doi: https://doi.org/10.1001/jamanetworkopen.2022.40332
  27. 27. Toepfner N, Brinkmann F, Augustin S, Stojanov S, Behrends U. Long COVID in pediatrics-epidemiology, diagnosis, and management. Eur J Pediatr. 2024 Apr;183(4):1543–53. doi: https://doi.org/10.1007/s00431-023-05360-y
  28. 28. Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, et al.; Global Burden of Disease Long COVID Collaborators. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022 Oct;328(16):1604–15. doi: https://doi.org/10.1001/jama.2022.18931
  29. 29. Steinmetz A, Gross S, Lehnert K, Lücker P, Friedrich N, Nauck M, et al. Longitudinal Clinical Features of Post-COVID-19 Patients-Symptoms, Fatigue and Physical Function at 3- and 6-Month Follow-Up. J Clin Med. 2023 Jun;12(12):3966. doi: https://doi.org/10.3390/jcm12123966
  30. 30. Ahmed S, Ahmad E, Ahmad B, Arif MH, Ilyas HM, Hashmi N, et al. Long COVID-19 and primary care: Challenges, management and recommendations. Semergen. 2024 Apr;50(3):102188. doi: https://doi.org/10.1016/j.semerg.2023.102188
  31. 31. Nehme M, Diem L, Bassetti CL, Guessous I. Swiss recommendations for the diagnosis, management and follow-up of post-COVID condition in primary care medicine (2023). Swiss Med Wkly. 2023 Sep;153(9):3468. doi: https://doi.org/10.57187/s.3468
  32. 32. Xie Y, Choi T, Al-Aly Z. Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras. N Engl J Med. 17 juill 2024;NEJMoa2403211.
  33. 33. Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023 Feb;2(1):e000385. doi: https://doi.org/10.1136/bmjmed-2022-000385
  34. 34. Britt H, Miller G, Bayram C, Henderson J, Valenti L, Harrison C, et al. A decade of Australian general practice activity 2006–07 to 2015–16. Syndney: Sydney University Press; 2016. (General practice series no. 40.).
  35. 35. da Silva MD, da Silva TS, Mendes CG, Valbão MC, Badu-Tawiah AK, Laurindo LF, et al. Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker Identification. Mol Diagn Ther. 2025 Sep;29(5):617–36. doi: https://doi.org/10.1007/s40291-025-00792-8
  36. 36. Espín E, Yang C, Shannon CP, Assadian S, He D, Tebbutt SJ. Cellular and molecular biomarkers of long COVID: a scoping review. EBioMedicine. 2023 May;91:104552. doi: https://doi.org/10.1016/j.ebiom.2023.104552
  37. 37. Wilhelm F, Cadamuro J, Mink S. Autoantibodies in long COVID: a systematic review. Lancet Infect Dis. 2025;(sept):S1473309925004116.

Most read articles by the same author(s)

1 2 3 > >>